quarta-feira, 7 de outubro de 2026
PesquisarExplore
Via News Knowledge File

U.S. Securities and Exchange Commission

government agency80% conf.·synced Oct 6, 2026

U.S. federal regulatory agency overseeing securities markets

0
sourced metrics
1710
relationships
8
stated objectives
0
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Stated objectives

Make the U.S. the crypto capital of the world

source
stated

Incorporate crypto into retirement programs through regulatory guidance

source
target: regulatory framework by 2026-01-01 00:00:00stated

Provide whistleblower rewards totaling up to 30% of any successful recovery for original information

source
target: 30 stated

Work toward allowing the inclusion of alternative assets in self-directed retirement plans

source
stated

Encourage whistleblowers to provide original information about securities violations through rewards program offering up to 30% of successful recoveries

source
target: 30 stated

SEC Whistleblower program incentivizing persons with non-public information about Hercules Capital securities violations to come forward with original information in exchange for monetary rewards

source
target: up to 30% of successful SEC enforcement recovery stated

Cut off opportunities for market manipulators to exploit small overseas IPO listings and protect mom-and-pop investors from pump-and-dump schemes.

source
stated

Establish dedicated crypto custody rules for registered investment advisors, funds and BDCs under federal securities law

source
stated

Relationship graph · 1710 connections

regulates
1435
regulated by
232
Employs
14
subsidiary of
5
Covered by
4
contracted by
4
files with
3
governs
2
This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com